Kevin R. Kozak

AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients

Tracy T. Batchelor, A. Gregory Sorensen, Emmanuelle di Tomaso et al. · Cancer Cell · 2007 · 1.8K citations · Full text

Normalizes Tumor Vasculature, Neuro-oncology, Novel Therapy +12

Oxygenation of the Endocannabinoid, 2-Arachidonylglycerol, to Glyceryl Prostaglandins by Cyclooxygenase-2

Kevin R. Kozak, Scott W. Rowlinson, Lawrence J. Marnett · Journal of Biological Chemistry · 2000 · 391 citations · Full text

Inflammation, Anti-inflammatory, Oxysterol +13

Metabolism of the Endocannabinoids, 2-Arachidonylglycerol and Anandamide, into Prostaglandin, Thromboxane, and Prostacyclin Glycerol Esters and Ethanolamides

Kevin R. Kozak, Brenda C. Crews, Jason D. Morrow et al. · Journal of Biological Chemistry · 2002 · 363 citations · Full text

Cannabis Use, Biosynthesis, Aldehyde Dehydrogenase +10

A Novel Mechanism of Cyclooxygenase-2 Inhibition Involving Interactions with Ser-530 and Tyr-385

Scott W. Rowlinson, James R. Kiefer, Jeffery J. Prusakiewicz et al. · Journal of Biological Chemistry · 2003 · 338 citations · Full text

Pharmaceutical Science, Pharmacotherapy, Chemical Biology +16

Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: Facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors

Amit S. Kalgutkar, Brenda C. Crews, Scott W. Rowlinson et al. · Proceedings of the National Academy of Sciences · 2000 · 251 citations · Full text

Medicinal Chemistry, Pharmaceutical Chemistry, Anti-inflammatory +15